Information on Ipratropium and Albuterol
The ipratropium and albuterol inhaler (Combivent®) is used to treat chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. However, it will not be available in its current form much longer. This product contains chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer; it will not be made, dispensed, or sold in the United States in its current form after December 31, 2013. The manufacturer is working on a reformulated, CFC-free version that is set to be available to consumers by the time the old formulation is phased out.